Hisamitsu Pharmaceutical Overview
- Year Founded
-
1944
- Status
-
Public
- Employees
-
3,697
- Stock Symbol
-
4530
- Investments
-
7
- Share Price
-
$27.07
- (As of Wednesday Closing)
Hisamitsu Pharmaceutical General Information
Description
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
Contact Information
Website
www.global.hisamitsuCorporate Office
- Tashirodaikan-machi 408
- Kyushu
- Tosu, Saga 841-0017
- Japan
Corporate Office
- Tashirodaikan-machi 408
- Kyushu
- Tosu, Saga 841-0017
- Japan
Hisamitsu Pharmaceutical Stock Performance
As of 23-Jul-2025, Hisamitsu Pharmaceutical’s stock price is $27.07. Its current market cap is $1.97B with 73M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $27.07 | $30.53 | $27.07 - $27.07 | $1.97B | 73M | 100.00 | $1.77 |
Hisamitsu Pharmaceutical Financials Summary
As of 28-Feb-2026, Hisamitsu Pharmaceutical has a trailing 12-month revenue of $1.09B.
|
In Thousands, USD |
TTM 28-Feb-2026 | FY 2026 28-Feb-2026 | FY 2025 28-Feb-2025 | FY 2024 29-Feb-2024 |
|---|---|---|---|---|
| Revenue | 1,087,392 | 1,087,392 | 1,022,703 | 990,022 |
| EBITDA | 189,218 | 189,218 | 211,724 | 152,388 |
| Net Income | 127,800 | 127,800 | 142,635 | 97,594 |
| Total Assets | 2,352,683 | 2,352,683 | 2,286,617 | 2,182,336 |
| Total Debt | 15,218 | 15,218 | 25,701 | 13,939 |
Hisamitsu Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Hisamitsu Pharmaceutical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Hisamitsu Pharmaceutical Investments & Acquisitions (7)
Hisamitsu Pharmaceutical’s most recent deal was a Later Stage VC with ReEir for . The deal was made on 17-Jul-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ReEir | 17-Jul-2025 | Later Stage VC | Drug Discovery | ||
| Orphe | 27-Mar-2025 | Later Stage VC | Footwear | ||
| ReEir | 09-Dec-2024 | Merger/Acquisition | Drug Discovery | ||
| AYUMI Pharmaceutical | 08-Mar-2022 | Secondary Transaction - Private | Pharmaceuticals | ||
| GAIA BioMedicine | 21-Sep-2021 | Later Stage VC | Drug Discovery |
Hisamitsu Pharmaceutical ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
30.02 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Hisamitsu Pharmaceutical Exits (1)
Hisamitsu Pharmaceutical’s most recent exit was on 08-Mar-2022 from AYUMI Pharmaceutical. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| AYUMI Pharmaceutical | 08-Mar-2022 | Completed |
|
Hisamitsu Pharmaceutical Affiliates
Subsidiaries (6)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| ReEir | Minato-ku, Japan | 2017 | |
| Sanofi-Hisamitsu K.K Kk | Tokyo, Japan | 2012 | |
| Hisamitsu Agency | Kurume, Japan | 2005 | |
| Sagacityvision | Saga, Japan | 1988 | |
| Crcc Media Co. | Kurume, Japan | 1988 |
Hisamitsu Pharmaceutical FAQs
-
When was Hisamitsu Pharmaceutical founded?
Hisamitsu Pharmaceutical was founded in 1944.
-
Where is Hisamitsu Pharmaceutical headquartered?
Hisamitsu Pharmaceutical is headquartered in Tosu, Japan.
-
What is the size of Hisamitsu Pharmaceutical?
Hisamitsu Pharmaceutical has 3,697 total employees.
-
What industry is Hisamitsu Pharmaceutical in?
Hisamitsu Pharmaceutical’s primary industry is Pharmaceuticals.
-
Is Hisamitsu Pharmaceutical a private or public company?
Hisamitsu Pharmaceutical is a Public company.
-
What is Hisamitsu Pharmaceutical’s stock symbol?
The ticker symbol for Hisamitsu Pharmaceutical is 4530.
-
What is the current stock price of Hisamitsu Pharmaceutical?
As of 23-Jul-2025 the stock price of Hisamitsu Pharmaceutical is $27.07.
-
What is the current market cap of Hisamitsu Pharmaceutical?
The current market capitalization of Hisamitsu Pharmaceutical is $1.97B.
-
What is Hisamitsu Pharmaceutical’s current revenue?
The trailing twelve month revenue for Hisamitsu Pharmaceutical is $1.09B.
-
What is Hisamitsu Pharmaceutical’s annual earnings per share (EPS)?
Hisamitsu Pharmaceutical’s EPS for 12 months was $1.77.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
